Literature DB >> 27331777

The Biomechanical Effects of Resuscitation Colloids on the Compromised Lung Endothelial Glycocalyx.

Kathleen M Job1, Ryan O'Callaghan, Vladimir Hlady, Alexandra Barabanova, Randal O Dull.   

Abstract

BACKGROUND: The endothelial glycocalyx is an important component of the vascular permeability barrier, forming a scaffold that allows serum proteins to create a gel-like layer on the endothelial surface and transmitting mechanosensing and mechanotransduction information that influences permeability. During acute inflammation, the glycocalyx is degraded, changing how it interacts with serum proteins and colloids used during resuscitation and altering its barrier properties and biomechanical characteristics. We quantified changes in the biomechanical properties of lung endothelial glycocalyx during control conditions and after degradation by hyaluronidase using biophysical techniques that can probe mechanics at (1) the aqueous/glycocalyx interface and (2) inside the glycocalyx. Our goal was to discern the location-specific effects of albumin and hydroxyethyl starch (HES) on glycocalyx function.
METHODS: The effects of albumin and HES on the mechanical properties of bovine lung endothelial glycocalyx were studied using a combination of atomic force microscopy and reflectance interference contrast microscopy. Logistic regression was used to determine the odds ratios for comparing the effects of varying concentrations of albumin and HES on the glycocalyx with and without hyaluronidase.
RESULTS: Atomic force microscopy measurements demonstrated that both 0.1% and 4% albumin increased the thickness and reduced the stiffness of glycocalyx when compared with 1% albumin. The effect of HES on glycocalyx thickness was similar to albumin, with thickness increasing significantly between 0.1% and 1% HES and a trend toward a softer glycocalyx at 4% HES. Reflectance interference contrast microscopy revealed a concentration-dependent softening of the glycocalyx in the presence of albumin, but a concentration-dependent increase in stiffness with HES. After glycocalyx degradation with hyaluronidase, stiffness was increased only at 4% albumin and 1% HES.
CONCLUSIONS: Albumin and HES induced markedly different effects on glycocalyx mechanics and had notably different effects after glycocalyx degradation by hyaluronidase. We conclude that HES is not comparable with albumin for studies of vascular permeability and glycocalyx-dependent signaling. Characterizing the molecular and biomechanical effects of resuscitation colloids on the glycocalyx should clarify their indicated uses and permit a better understanding of how HES and albumin affect vascular function.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27331777      PMCID: PMC5189664          DOI: 10.1213/ANE.0000000000001284

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  50 in total

Review 1.  Endothelial glycocalyx: permeability barrier and mechanosensor.

Authors:  F E Curry; R H Adamson
Journal:  Ann Biomed Eng       Date:  2011-10-19       Impact factor: 3.934

2.  Regulation of capillary hydraulic conductivity in response to an acute change in shear.

Authors:  Min-ho Kim; Norman R Harris; John M Tarbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-01       Impact factor: 4.733

3.  Fluorescence correlation spectroscopy can probe albumin dynamics inside lung endothelial glycocalyx.

Authors:  Andrew P Stevens; Vladimir Hlady; Randal O Dull
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-05-04       Impact factor: 5.464

4.  Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability.

Authors:  Matthias Jacob; Dirk Bruegger; Markus Rehm; Ulrich Welsch; Peter Conzen; Bernhard F Becker
Journal:  Anesthesiology       Date:  2006-06       Impact factor: 7.892

Review 5.  Fluid management in thoracic surgery.

Authors:  Sherif Assaad; Wanda Popescu; Albert Perrino
Journal:  Curr Opin Anaesthesiol       Date:  2013-02       Impact factor: 2.706

6.  Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability.

Authors:  Matthias Jacob; Thomas Saller; Daniel Chappell; Markus Rehm; Ulrich Welsch; Bernhard F Becker
Journal:  Basic Res Cardiol       Date:  2013-04-06       Impact factor: 17.165

7.  Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy.

Authors:  Sisse R Ostrowski; Pär I Johansson
Journal:  J Trauma Acute Care Surg       Date:  2012-07       Impact factor: 3.313

Review 8.  Inflammatory response to trauma: implications for coagulation and resuscitation.

Authors:  Albert Pierce; Jean-François Pittet
Journal:  Curr Opin Anaesthesiol       Date:  2014-04       Impact factor: 2.706

9.  The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity.

Authors:  Bushra Gorsi; Feng Liu; Xing Ma; Timothy J A Chico; Ashok v; Kenneth L Kramer; Esther Bridges; Rui Monteiro; Adrian L Harris; Roger Patient; Sally E Stringer
Journal:  Angiogenesis       Date:  2014-01       Impact factor: 9.596

10.  Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia.

Authors:  Markus Rehm; Dirk Bruegger; Frank Christ; Peter Conzen; Manfred Thiel; Matthias Jacob; Daniel Chappell; Mechthild Stoeckelhuber; Ulrich Welsch; Bruno Reichart; Klaus Peter; Bernhard F Becker
Journal:  Circulation       Date:  2007-10-08       Impact factor: 29.690

View more
  8 in total

1.  Differential effects of obesity on visceral versus subcutaneous adipose arteries: role of shear-activated Kir2.1 and alterations to the glycocalyx.

Authors:  Sang Joon Ahn; Elizabeth Le Master; James C Lee; Shane A Phillips; Irena Levitan; Ibra S Fancher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-12-10       Impact factor: 4.733

2.  Effects of 5% Albumin Plus Saline Versus Saline Alone on Outcomes From Large-Volume Resuscitation in Critically Ill Patients.

Authors:  Hernando Gomez; Priyanka Priyanka; Ayham Bataineh; Christopher M Keener; Gilles Clermont; John A Kellum
Journal:  Crit Care Med       Date:  2021-01-01       Impact factor: 9.296

Review 3.  The Endothelial Glycocalyx: A Fundamental Determinant of Vascular Permeability in Sepsis.

Authors:  Jaime Fernández-Sarmiento; Lina María Salazar-Peláez; Joseph A Carcillo
Journal:  Pediatr Crit Care Med       Date:  2020-05       Impact factor: 3.971

Review 4.  Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review.

Authors:  Cesar Aldecoa; Juan V Llau; Xavier Nuvials; Antonio Artigas
Journal:  Ann Intensive Care       Date:  2020-06-22       Impact factor: 6.925

Review 5.  Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases.

Authors:  Sophie Dogné; Bruno Flamion; Nathalie Caron
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-06-07       Impact factor: 8.311

6.  The Beneficial Effect of HES on Vascular Permeability and Its Relationship With Endothelial Glycocalyx and Intercellular Junction After Hemorrhagic Shock.

Authors:  Hongliang Zhao; Yu Zhu; Jie Zhang; Yue Wu; Xinming Xiang; Zisen Zhang; Tao Li; Liangming Liu
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

7.  The protective effect of hydroxyethyl starch solution on the glycocalyx layer in an acute hemorrhage mouse model.

Authors:  Kohji Uzawa; Akira Ushiyama; Shingo Mitsuda; Tadao Ando; Marie Sawa; Hideki Miyao; Tomoko Yorozu
Journal:  J Anesth       Date:  2019-10-15       Impact factor: 2.078

8.  6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice.

Authors:  Andreas Margraf; Jan M Herter; Katharina Kühne; Anika Stadtmann; Thomas Ermert; Manuel Wenk; Melanie Meersch; Hugo Van Aken; Alexander Zarbock; Jan Rossaint
Journal:  Crit Care       Date:  2018-05-01       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.